AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal

BSE1683.60-27.45 (-1.6 %)

PREV CLOSE ( ) 1711.05

OPEN PRICE ( ) 1884.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2918

TODAY'S LOW / HIGH ( )1664.80 1884.40

52 WK LOW / HIGH ( )1593.3 2420

NSE1683.40-29.65 (-1.73 %)

PREV CLOSE( ) 1713.05

OPEN PRICE ( ) 1722.10

BID PRICE (QTY) 1683.40 (20)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 36264

TODAY'S LOW / HIGH( ) 1661.55 1723.00

52 WK LOW / HIGH ( )1592.65 2435

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-12 1979

Management Info

Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director

Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

NEWS

16May Ajanta Pharma informs about disclosure
Ajanta Pharma has informed that the exchange has received the disclosure..

13May Ajanta Pharma informs about annual com
Ajanta Pharma has informed that it enclosed copy of the Annual Secretari..

11May Ajanta Pharma informs about audio call
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

10May Allotment of Bonus Equity Shares
Bonus issue Inter alia, approved: 1. Approved issue of bonus s..

02May Board Meeting Intimation for Audited
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Dire..

Financials

in Millions

	QTR Mar 22	ANNUAL 22
Net Profit	1348.4	7198.6
Gross Profit	1783	9005.4
Operating Profit	2155.7	10306.2
Net Sales	7656.3	31406.4

EVENT CALENDAR

peer group

Gland Pharma (BSE) 3109.65 (3.81%)	M.Cap ( in Cr)51177.54
Piramal Enterprises (BSE) 1875.00 (3.39%)	M.Cap ( in Cr)44749.44
Hester Biosciences (BSE) 2370.35 (2.15%)	M.Cap ( in Cr)2016.42
AMI Organics (BSE) 981.50 (4.54%)	M.Cap ( in Cr)3576.30
Supriya Lifescience (BSE) 363.75 (12.22%)	M.Cap ( in Cr)2927.56

	NON-INSTITUTION	8.14%
	PROMOTERS	70.48%
	MUTUAL FUNDS/UTI	10.5%
	FI/BANKS/INSURANCE	1.11%
	GOVERNMENT	0.45%
	FII	0%

Scheme Name	Hold(%)
Mirae Asset Healthc...	3.14
UTI Healthcare Fund...	3.07
BOI AXA Midcap Tax ...	2.53
ITI Pharma & Health...	2.46
UTI Core Equity Fun...	2.39
Aditya Birla SL Pha...	2.25

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. was incorporated in the year 1979. Its today's share price is 1683.6. Its current market capitalisation stands at Rs 14380.77 Cr. In the latest quarter, company has reported Gross Sales of Rs. 27185.9 Cr and Total Income of Rs.28221.6 Cr. The company's management includes Gaurang Shah, Anjana Grewal, Prabhakar Dalal, KH Viswanathan, Chandrakant M Khetan, Rajesh M Agrawal, Yogesh M Agrawal, Madhusudan B Agrawal, Mannalal B Agrawal.

It is listed on the BSE with a BSE Code of 532331 , NSE with an NSE Symbol of AJANTPHARM and ISIN of INE031B01049. It's Registered office is at Ajanta House,Charkop ,Kandivali (W)Mumbai-400067, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Kapoor & Parekh Associates

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI Scores RMS Policy Inspection CSR Committee CSR Policy CSR Activities Investor Charter Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs

Investor Complaint Data

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote